Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L, Canaran G, Rylett RJ, Neufeld RW.

Arch Gen Psychiatry. 1997 Oct;54(10):959-65.

PMID:
9337777
2.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
3.

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.

Abbott C, Bustillo J.

Curr Opin Psychiatry. 2006 Mar;19(2):135-9. Review.

PMID:
16612192
4.

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.

Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, Thompson RT.

Schizophr Bull. 1996;22(4):597-609.

PMID:
8938914
5.

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC.

Arch Gen Psychiatry. 2007 Feb;64(2):193-200.

PMID:
17283286
6.

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.

van Elst LT, Valerius G, Büchert M, Thiel T, Rüsch N, Bubl E, Hennig J, Ebert D, Olbrich HM.

Biol Psychiatry. 2005 Nov 1;58(9):724-30. Epub 2005 Jul 14.

PMID:
16018980
7.

Proton MR spectroscopy in Lesch-Nyhan disease.

Davanzo P, Ke Y, Thomas MA, Anderson C, King B, Belin T, Levitt J, Curran J, Guze B.

AJNR Am J Neuroradiol. 1998 Apr;19(4):672-4.

8.
9.

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

Bartha R, al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, Densmore M, Canaran G, Neufeld RW.

Biol Psychiatry. 1999 Jun 1;45(11):1403-11.

PMID:
10356621
10.

Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study.

Shirayama Y, Obata T, Matsuzawa D, Nonaka H, Kanazawa Y, Yoshitome E, Ikehira H, Hashimoto K, Iyo M.

Neuroimage. 2010 Feb 1;49(3):2783-90. doi: 10.1016/j.neuroimage.2009.10.031. Epub 2009 Oct 19.

PMID:
19850131
11.

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC.

Arch Gen Psychiatry. 2012 May;69(5):449-59. doi: 10.1001/archgenpsychiatry.2011.1519. Epub 2012 Jan 2.

PMID:
22213769
12.

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy.

Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A, Thompson RT.

Arch Gen Psychiatry. 1995 May;52(5):399-406. Erratum in: Arch Gen Psychiatry 1995 Oct;52(10):799.

PMID:
7726721
13.

Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.

Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, Ryan CM, Kim JE, Renshaw PF, Jacobson AM.

Arch Gen Psychiatry. 2009 Aug;66(8):878-87. doi: 10.1001/archgenpsychiatry.2009.86.

PMID:
19652127
14.

Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1)H spectroscopy study.

Nery FG, Stanley JA, Chen HH, Hatch JP, Nicoletti MA, Monkul ES, Matsuo K, Caetano SC, Peluso MA, Najt P, Soares JC.

Psychiatry Res. 2009 Dec 30;174(3):177-83. doi: 10.1016/j.pscychresns.2009.05.003. Epub 2009 Nov 11.

PMID:
19910168
15.

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.

Steel RM, Bastin ME, McConnell S, Marshall I, Cunningham-Owens DG, Lawrie SM, Johnstone EC, Best JJ.

Psychiatry Res. 2001 May 30;106(3):161-70.

PMID:
11382538
16.

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.

Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC.

Neurology. 1999 Jul 13;53(1):71-9.

PMID:
10408539
17.

Proton MRS in twin pairs discordant for schizophrenia.

Lutkenhoff ES, van Erp TG, Thomas MA, Therman S, Manninen M, Huttunen MO, Kaprio J, Lönnqvist J, O'Neill J, Cannon TD.

Mol Psychiatry. 2010 Mar;15(3):308-18. doi: 10.1038/mp.2008.87. Epub 2008 Jul 22.

PMID:
18645571
18.

The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, Schnepf B, Boeker H, Boesiger P, Northoff G.

Arch Gen Psychiatry. 2009 May;66(5):478-86. doi: 10.1001/archgenpsychiatry.2009.39.

PMID:
19414707
19.

Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study.

Grachev ID, Fredrickson BE, Apkarian AV.

Pain. 2000 Dec 15;89(1):7-18.

PMID:
11113288
20.

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B.

Schizophr Res. 2005 Mar 1;73(2-3):153-7.

PMID:
15653258

Supplemental Content

Support Center